A Multicenter, Randomized, Dose-Ranging, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Moderate to Severe Platysmal Bands
Latest Information Update: 25 Aug 2022
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscular disorders
- Focus Therapeutic Use
- Sponsors Galderma Research & Development
Most Recent Events
- 18 Jun 2020 Status changed from recruiting to completed.
- 03 Oct 2019 Status changed from not yet recruiting to recruiting.
- 10 Sep 2019 New trial record